Ligand validation:2BY2

BME: BETA-MERCAPTOETHANOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BY2_BME_A_1607	97%	93%	0.07	0.984	0.28	0.21	-	-	1	0	100%	0.9
2BY0_BME_A_1607	96%	95%	0.07	0.977	0.33	0.06	-	-	1	0	100%	0.85
2BHZ_BME_A_1610	96%	94%	0.078	0.985	0.26	0.17	-	-	0	0	100%	1
2BHY_BME_A_1612	91%	93%	0.086	0.973	0.09	0.39	-	-	2	0	100%	0.9
2BXZ_BME_A_1608	85%	52%	0.092	0.957	0.26	1.56	-	-	2	0	100%	0.85
2BY3_BME_A_1607	73%	80%	0.11	0.936	0.36	0.49	-	-	1	0	100%	0.9
1E46_BME_P_302	100%	59%	0.026	0.993	0.51	1.03	-	-	0	0	100%	1
1DYF_BME_A_179	100%	79%	0.029	0.992	0.55	0.33	-	-	0	0	100%	1
1L56_BME_A_165	100%	74%	0.025	0.989	0.84	0.18	-	-	1	0	100%	1
1L73_BME_A_900	100%	77%	0.025	0.986	0.33	0.57	-	-	1	0	100%	1
1DYG_BME_A_179	100%	74%	0.033	0.991	0.57	0.44	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.